Definition
Florida SB 844 is a 2026 Florida law that changes the content of the state’s required controlled-substance prescribing continuing education course by adding instruction on treating pain in patients with sickle cell disease, effective July 1, 2026. It does not create a separate new CE hour; it changes what must be covered inside the existing required course for practitioners who must complete it. Florida Senate bill summary Florida Statutes 456.0301
In practical terms, the buyer question is not “Do I owe another Florida mandate?” but “Does my Florida controlled-substance course now include sickle cell disease pain management content?” That distinction matters because Florida licensees often get tripped up by mandate changes that alter course content rather than total CE volume. Florida Senate bill text
Why this matters for Florida prescribers
The law targets the standard two-hour controlled-substance prescribing course required for certain Florida practitioners who are registered with the U.S. Drug Enforcement Administration and authorized to prescribe controlled substances. Starting July 1, 2026, that course must include information on pain treatment for patients with sickle cell disease. Florida Board of Medicine Florida Board of Osteopathic Medicine
The important nuance is scope. SB 844 is a content amendment to an existing prescribing-education requirement under section 456.0301, not a standalone sickle cell CE requirement that all Florida clinicians must separately track. For renewal planning, what changes first is course selection: older controlled-substance courses may no longer be the right fit if they have not been updated for the July 1, 2026 standard. Florida Senate staff analysis
Who this affects
SB 844 applies through Florida’s existing controlled-substance prescribing CE framework, which is tied to practitioners who are DEA-registered and authorized to prescribe controlled substances under the relevant Florida licensing rules and statutes. The exact renewal mechanics still depend on profession-specific board rules, but the core trigger is not “all healthcare professionals”; it is the controlled-substance prescriber requirement. Florida Statutes 456.0301 Florida Department of Health Take Control
-
Florida physicians with DEA registration are within the existing two-hour prescribing-course requirement. Florida Board of Medicine
-
Florida osteopathic physicians with DEA registration are also required to complete a board-approved two-hour prescribing course. Florida Board of Osteopathic Medicine
-
Florida dentists complete a two-hour safe and effective prescribing course at renewal under board requirements. Florida Board of Dentistry
-
Florida advanced practice registered nurses who prescribe controlled substances are affected through the Board of Nursing’s safe and effective prescription of controlled substances requirement. The Florida Board of Nursing lists a three-hour controlled-substances course for APRN renewal, which is the nursing-specific requirement buyers usually need to distinguish from the two-hour physician and dentist framework. Florida Board of Nursing APRN renewal
-
Florida nurses who do not prescribe controlled substances are not the practical target of SB 844. Registered nurses and licensed practical nurses have their own renewal CE requirements, but SB 844 matters through the controlled-substance prescribing obligation rather than as a universal nursing CE mandate. Florida Board of Nursing RN renewal
-
Other professions may intersect with the requirement through their own board rules, so the right check is always the profession’s renewal page plus whether the licensee is actually subject to the controlled-substance prescribing mandate. Florida Department of Health Take Control
What changed on July 1, 2026
Before SB 844, Florida already required a board-approved controlled-substance prescribing course for covered prescribers. After SB 844, the course must also address treatment of pain for patients with sickle cell disease. The law took effect on July 1, 2026. Florida Senate bill summary
| Question | Before SB 844 | After July 1, 2026 |
|---|---|---|
| Is there a Florida controlled-substance prescribing CE requirement? | Yes | Yes |
| Is sickle cell disease pain treatment part of that course? | Not specifically required by this law | Yes, required course content |
| Does the law add a separate extra CE hour? | No | No |
| Effective date | Prior rule structure | July 1, 2026 |
Table basis: Florida Senate bill text
SB 844 applicability breakdown for Florida nurse practitioners and other prescribers
Does Florida SB 844 apply to nurse practitioners?
Yes, Florida SB 844 matters for nurse practitioners when they are advanced practice registered nurses completing the state’s controlled-substance prescribing education requirement. The Florida Board of Nursing’s APRN renewal page lists a three-hour safe and effective prescription of controlled substances course, and SB 844 changes the content that controlled-substance prescribing education must include by adding sickle cell disease pain-treatment instruction. Florida Board of Nursing APRN renewal Florida Senate bill summary
Do Florida nurses who do not prescribe need SB 844 CE?
Usually no. SB 844 is not a standalone nursing course requirement for all Florida nurses; it changes controlled-substance prescribing CE content for licensees who are actually subject to that prescribing requirement. That is why the practical first check is whether the nurse is an APRN or other prescriber who must complete controlled-substance education, not whether they simply hold a Florida nursing license. Florida Board of Nursing RN renewal Florida Department of Health Take Control
Is SB 844 an extra two hours of CE for Florida prescribers?
No. SB 844 does not add an extra two hours of CE for Florida prescribers; it adds sickle cell disease pain-management content to an existing controlled-substance prescribing course. That distinction is the part buyers most often miss, especially when renewal research is already confusing and course titles look similar across providers. Florida Senate staff analysis
Which controlled substance CE do Florida nurse practitioners need after SB 844?
Florida nurse practitioners should look for the Board of Nursing’s required safe and effective prescription of controlled substances course and confirm that the course reflects the post–July 1, 2026 SB 844 sickle cell disease content update. For APRNs, the main buying mistake is assuming any generic opioid or prescribing course will do when the real requirement is the nursing-board-controlled-substances course with the updated content standard. Florida Board of Nursing continuing education
Usage examples
Example 1: Florida physician renewing after July 1, 2026
A Florida MD with DEA registration does not need a separate “sickle cell CE” certificate. They need a controlled-substance prescribing course that has been updated to include sickle cell disease pain-management content. Florida Board of Medicine
Example 2: Florida dentist choosing a renewal course
A dentist comparing CE options should verify that the prescribing course reflects the post–July 1, 2026 content standard, rather than assuming any older two-hour opioid or prescribing module still fits the requirement unchanged. Florida Board of Dentistry Florida Senate bill summary
Example 3: Florida APRN deciding whether SB 844 changes total hours
A Florida nurse practitioner should not read SB 844 as a new standalone nursing mandate. The practical question is whether the APRN’s controlled-substance prescribing course now includes sickle cell disease pain-treatment content, not whether the state added another separate CE item to the renewal checklist. Florida Board of Nursing APRN renewal
Example 4: Buyer evaluating Renew Now CE
A Florida APRN or other prescriber looking for a course that tracks the updated rule would want to confirm that the course explicitly states it was updated for SB 844 and includes sickle cell pain-treatment content. Renew Now CE’s Florida controlled-substance prescribing course does exactly that on its course page. Renew Now CE course page
Common misconceptions
“What is Florida SB 844?”
Florida SB 844 is a 2026 law that adds sickle cell disease pain-treatment instruction to Florida’s existing controlled-substance prescribing CE framework. It is a content change inside an existing requirement, not a new standalone course category. Florida Senate bill summary
“SB 844 creates a brand-new Florida CE requirement.”
Not exactly. It changes the required content inside an existing controlled-substance prescribing course. For most buyers, that means the compliance task is course validation, not adding another item to the renewal checklist. Florida Senate staff analysis
“Every Florida healthcare licensee has to take this.”
No. The underlying requirement is tied to practitioners who fall under Florida’s controlled-substance prescribing CE rules, generally those registered with the DEA and authorized to prescribe controlled substances. Florida Statutes 456.0301
“I need a separate sickle cell certificate.”
The law does not require a separate standalone certificate for sickle cell disease pain management. What matters is that the required prescribing course includes that content. Florida Senate bill text
How this shows up in Renew Now CE’s catalog
Renew Now CE offers a Florida controlled-substance prescribing course that states it was updated for SB 844 and now includes the sickle cell disease pain-management requirement. For buyers, the practical advantage is straightforward: you can validate the mandate change on the course page itself instead of inferring compliance from an older generic opioid-prescribing title. Renew Now CE course page
If you are trying to verify whether a specific course fits your renewal obligation, the more reliable workflow is to match the course language to the board requirement and effective date, then confirm whether your profession is actually subject to the prescribing-course mandate. Renew Now CE also has a related guide on how to verify whether a CE course fits your license renewal requirement.
Related terms
-
Controlled-substance prescribing CE: Florida’s required continuing education course for certain DEA-registered practitioners authorized to prescribe controlled substances. Florida Statutes 456.0301
-
DEA registration: Federal registration with the U.S. Drug Enforcement Administration that is part of the trigger for Florida’s prescribing-course requirement. Florida Statutes 456.0301
-
Sickle cell disease pain management: The clinical topic SB 844 adds to the required Florida prescribing course content beginning July 1, 2026. Florida Senate bill summary
-
Board-approved course: A course accepted by the relevant Florida licensing board for satisfying a mandatory renewal requirement. Florida Board of Medicine
Frequently asked questions
Does Florida SB 844 apply to nurse practitioners?
Yes, Florida SB 844 applies in practice to nurse practitioners who are advanced practice registered nurses completing Florida’s controlled-substance prescribing education requirement. The Florida Board of Nursing requires APRNs to complete a three-hour safe and effective prescription of controlled substances course, and SB 844 changes the content that controlled-substance education must include by adding sickle cell disease pain-treatment instruction effective July 1, 2026. Florida Board of Nursing APRN renewal Florida Senate bill summary
What is Florida SB 844?
Florida SB 844 is a 2026 Florida law that adds sickle cell disease pain-management content to the state’s existing controlled-substance prescribing CE requirement. It does not create a separate sickle cell course or a new standalone CE category; it changes what covered prescribing courses must teach starting July 1, 2026. Florida Senate bill text
Is SB 844 an extra two hours of CE for Florida prescribers?
No, SB 844 is not an extra two hours of CE for Florida prescribers. The law amends course content inside an existing controlled-substance prescribing requirement, which is why the real buying question is whether a course has been updated for the new sickle cell disease content rather than whether a licensee owes another separate CE block. Florida Senate staff analysis of SB 844
Do Florida nurses who do not prescribe need SB 844 CE?
Usually no, because SB 844 matters through controlled-substance prescribing requirements rather than as a universal nursing CE mandate. Florida nurses who do not prescribe controlled substances should check their own renewal requirements, but the law’s practical effect is on prescribers who must complete controlled-substance education, not on every RN or LPN by default. Florida Board of Nursing RN renewal Florida Department of Health Take Control overview
Which controlled substance CE do Florida nurse practitioners need after SB 844?
Florida nurse practitioners should look for the Board of Nursing’s required safe and effective prescription of controlled substances course and confirm that it includes the SB 844 sickle cell disease pain-treatment content. The Florida Board of Nursing lists this as a three-hour APRN renewal requirement, so the practical check is course fit and updated content, not a search for a separate “SB 844 course.” Florida Board of Nursing continuing education
How can I tell whether a Florida prescribing CE course is actually updated for SB 844?
The safest way is to look for course language that specifically says the course includes sickle cell disease pain-management content and was updated for the July 1, 2026 Florida requirement. This matters because SB 844 changed what the controlled-substance course must cover, not the course title or total hours. How to verify whether a CE course fits your license renewal requirement Renew Now CE course page